We are live on ! Find out more
RKDA icon

Arcadia Biosciences

19 hedge funds and large institutions have $2.82M invested in Arcadia Biosciences in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

99% more capital inflows, than outflows

Capital inflows: $1.52M | Capital outflows: $767K

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

6% more funds holding

Funds holding: 18 → 19 (+1)

2.31% more ownership

Funds ownership: 8.12% → 10.43% (+2.3%)

37% less call options, than puts

Call options by funds: $88K | Put options by funds: $139K

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
5
Closed
1
Calls
$88​K
Puts
$139​K
Net Calls
-⁠$51​K
Net Calls Change
-⁠$51​K

RKDA Hedge Fund Activity: Q4 2020 in Review

19 of the 5,680 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2020, worth a combined $2.82M — up 16% from $2.44M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new RKDA positions and 1 closed out — a net gain of 1 holder — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Ardsley Advisory Partners, adding an estimated $840K. The largest seller was Sabby Management, cutting an estimated $741K.

  • 19 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2020, up from 18 in Q3 2020.
  • Funds reported $2.82M of Arcadia Biosciences stock for Q4 2020, up 16% quarter-over-quarter.
  • 2 funds opened new Arcadia Biosciences positions in Q4 2020 and 1 closed out, a net change of +1 holder.
  • The largest Arcadia Biosciences buyer in Q4 2020 was Ardsley Advisory Partners, an estimated $840K added.
  • The largest Arcadia Biosciences seller in Q4 2020 was Sabby Management, an estimated $741K sold.

Based on aggregated 13F filings for Q4 2020.